Modulating effect on BUN, SCr, CCr, urine protein, and serum albumin levels. Reducing fasting blood glucose, albuminuria levels, and reversing the glomerular hyperfiltration state
Downregulating the levels of urinary mALB, alpha1-MG, IgG, TF, RBP, and NAG. Decreasing the levels of vWF, ICAM-1, and VCAM-1. Raise the plasma NO level and improve the endothelium dependent vascular dilating function
Modulating effect on levels of TGF-, collagen IV, ED-1, RAGE, malondialdehyde, LPO and SOD. Upregulating the level of endothelial NO synthase and downregulating the levels of TNF-α, ICAM-1, and VACM-1
Increasing concentrations of malondialdehyde and level of 8-hydroxy-2′-deoxyguanosine. Decreasing the levels of LPO and increasing the levels of CAT, GST, and GSH
Downregulation in LPO. Upregulating the levels of SOD, catalase, GSH peroxidase, GST, GSH reductase and glucose-6-phosphate dehydrogenase, GSH, and total TSH and NPSH
Antagonizing TNF-α-mediated decrease in PPAR-γ and blocked transactivation of NF-κB and repression of PPAR-γ. Attenuating myocardial dysfunction through Akt/GSK-3β signaling pathway
Attenuating apoptotic incidence by regulating Akt and HIF-1 signaling pathways. Significant attenuation of phosphatase and tensin homolog deleted on chromosome 10 and upregulation of phospho-Akt and c-Raf levels. ACE inhibiting effect
Downregulating the levels of malondialdehyde, NO, and protein carbonyl. Suppression of the neutrophil infiltration and preventing the fall in mean arterial pressure and HR during ischemia-reperfusion